IDS, a leading producer of diagnostic testing kits, announces the appointment of Christopher Ian Cookson as Operations Director of the company with effect from 1 November. Ian Cookson, aged 53, brings more than 20 years of experience gained in senior appointments within the In Vitro Diagnostics (IVD) industry, and a skill set of particular relevance […]
IDS, a leading producer of diagnostic testing kits, announces that following the creation of IDS Nordic in the wake of acquiring Nordic Bioscience Diagnostics (NBD), the company has appointed Dr Dagmar Kasper, aged 41, as Business Development Manager and Country Manager. Dr Kasper attended Philipps University, Marburg, Germany, where she studied human biology and medicine, before […]
IDS, a leading producer of diagnostic testing kits, announces the completion of the acquisition of 99.93% of the ordinary share capital of Biocode Hycel S.A. (Biocode). As previously announced, the initial consideration for Biocode was €23,000,000, with €11,000,000 to be satisfied in cash, and the balance satisfied through the issue of 2,839,719 new Ordinary Shares […]
IDS, a leading producer of diagnostic testing kits, announces the completion of the acquisition of 100% of the ordinary share capital of Nordic Bioscience Diagnostics A/S (NBD). As previously announced, the consideration for NBD was £17,000,000, with £10,000,000 (€14,900,000) to be satisfied in cash, and the balance satisfied through the issue of 2,783,300 new Ordinary […]
IDS, a leading producer of diagnostic testing kits, announces the completion of the acquisition of 99.93% of the ordinary share capital of Biocode Hycel S.A. (Biocode). As previously announced, the initial consideration for Biocode was €23,000,000, with €11,000,000 to be satisfied in cash, and the balance satisfied through the issue of 2,839,719 new Ordinary Shares […]
